

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.00825012 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 6.49922153 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.49922153 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 5.66103962 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.43046860 |
| 6 | respiratory electron transport chain (GO:0022904) | 5.13027821 |
| 7 | electron transport chain (GO:0022900) | 5.02375878 |
| 8 | viral transcription (GO:0019083) | 4.94940050 |
| 9 | ribosomal small subunit biogenesis (GO:0042274) | 4.91552656 |
| 10 | translational termination (GO:0006415) | 4.81418368 |
| 11 | oxidative phosphorylation (GO:0006119) | 4.63075143 |
| 12 | NADH dehydrogenase complex assembly (GO:0010257) | 4.61615163 |
| 13 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.61615163 |
| 14 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.61615163 |
| 15 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.60490417 |
| 16 | proteasome assembly (GO:0043248) | 4.59988271 |
| 17 | cotranslational protein targeting to membrane (GO:0006613) | 4.58725120 |
| 18 | DNA deamination (GO:0045006) | 4.53775564 |
| 19 | protein targeting to ER (GO:0045047) | 4.51349602 |
| 20 | protein complex biogenesis (GO:0070271) | 4.49215150 |
| 21 | cullin deneddylation (GO:0010388) | 4.40372566 |
| 22 | translational elongation (GO:0006414) | 4.39064968 |
| 23 | protein localization to endoplasmic reticulum (GO:0070972) | 4.33814047 |
| 24 | maturation of SSU-rRNA (GO:0030490) | 4.31750950 |
| 25 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.29260967 |
| 26 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.26712550 |
| 27 | protein deneddylation (GO:0000338) | 4.15624786 |
| 28 | rRNA modification (GO:0000154) | 4.13743396 |
| 29 | chaperone-mediated protein transport (GO:0072321) | 4.07315343 |
| 30 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.05788031 |
| 31 | establishment of integrated proviral latency (GO:0075713) | 4.02200624 |
| 32 | regulation of mitochondrial translation (GO:0070129) | 4.00371353 |
| 33 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.95953944 |
| 34 | translation (GO:0006412) | 3.90960070 |
| 35 | positive regulation of ligase activity (GO:0051351) | 3.87328430 |
| 36 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.86307017 |
| 37 | cellular protein complex disassembly (GO:0043624) | 3.86098367 |
| 38 | * regulation of cellular amino acid metabolic process (GO:0006521) | 3.85545551 |
| 39 | viral life cycle (GO:0019058) | 3.84192391 |
| 40 | translational initiation (GO:0006413) | 3.80584196 |
| 41 | ribosomal large subunit biogenesis (GO:0042273) | 3.73567832 |
| 42 | protein neddylation (GO:0045116) | 3.71860287 |
| 43 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.71083570 |
| 44 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.68404229 |
| 45 | ATP biosynthetic process (GO:0006754) | 3.66399764 |
| 46 | respiratory chain complex IV assembly (GO:0008535) | 3.66093318 |
| 47 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.63958321 |
| 48 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.63958321 |
| 49 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.63462567 |
| 50 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.61915987 |
| 51 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.61864083 |
| 52 | termination of RNA polymerase III transcription (GO:0006386) | 3.61864083 |
| 53 | * negative regulation of ligase activity (GO:0051352) | 3.61832237 |
| 54 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.61832237 |
| 55 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.61555655 |
| 56 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.60989581 |
| 57 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.60989581 |
| 58 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.60989581 |
| 59 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.59493827 |
| 60 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.58355523 |
| 61 | inner mitochondrial membrane organization (GO:0007007) | 3.56837346 |
| 62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.55616524 |
| 63 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.55182505 |
| 64 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.54360913 |
| 65 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.52429358 |
| 66 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.52429358 |
| 67 | cellular component biogenesis (GO:0044085) | 3.51337532 |
| 68 | formation of translation preinitiation complex (GO:0001731) | 3.47721325 |
| 69 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.47611524 |
| 70 | protein maturation by protein folding (GO:0022417) | 3.46646430 |
| 71 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.46209424 |
| 72 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.45565205 |
| 73 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.45336807 |
| 74 | GTP biosynthetic process (GO:0006183) | 3.44601274 |
| 75 | establishment of protein localization to mitochondrion (GO:0072655) | 3.44098101 |
| 76 | protein targeting to mitochondrion (GO:0006626) | 3.43867704 |
| 77 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.43752338 |
| 78 | * regulation of ligase activity (GO:0051340) | 3.42327269 |
| 79 | hydrogen ion transmembrane transport (GO:1902600) | 3.41984064 |
| 80 | pseudouridine synthesis (GO:0001522) | 3.40364916 |
| 81 | DNA strand elongation (GO:0022616) | 3.40345541 |
| 82 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.40087670 |
| 83 | 7-methylguanosine mRNA capping (GO:0006370) | 3.39228424 |
| 84 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.38483635 |
| 85 | aerobic respiration (GO:0009060) | 3.36425009 |
| 86 | establishment of viral latency (GO:0019043) | 3.35098022 |
| 87 | mitochondrial transport (GO:0006839) | 3.34210501 |
| 88 | 7-methylguanosine RNA capping (GO:0009452) | 3.34125923 |
| 89 | RNA capping (GO:0036260) | 3.34125923 |
| 90 | purine nucleobase biosynthetic process (GO:0009113) | 3.31072287 |
| 91 | spliceosomal snRNP assembly (GO:0000387) | 3.30291142 |
| 92 | protein complex disassembly (GO:0043241) | 3.29968013 |
| 93 | * regulation of cellular amine metabolic process (GO:0033238) | 3.28977344 |
| 94 | CENP-A containing nucleosome assembly (GO:0034080) | 3.28429133 |
| 95 | L-methionine salvage (GO:0071267) | 3.27274766 |
| 96 | L-methionine biosynthetic process (GO:0071265) | 3.27274766 |
| 97 | amino acid salvage (GO:0043102) | 3.27274766 |
| 98 | rRNA methylation (GO:0031167) | 3.24166508 |
| 99 | chromatin remodeling at centromere (GO:0031055) | 3.24139251 |
| 100 | iron-sulfur cluster assembly (GO:0016226) | 3.24022803 |
| 101 | metallo-sulfur cluster assembly (GO:0031163) | 3.24022803 |
| 102 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.22774052 |
| 103 | positive regulation of cell cycle arrest (GO:0071158) | 3.22052304 |
| 104 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.21139613 |
| 105 | macromolecular complex disassembly (GO:0032984) | 3.20080175 |
| 106 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.18231324 |
| 107 | peptidyl-histidine modification (GO:0018202) | 3.17109226 |
| 108 | UTP biosynthetic process (GO:0006228) | 3.16387947 |
| 109 | nucleobase biosynthetic process (GO:0046112) | 3.15789455 |
| 110 | cytochrome complex assembly (GO:0017004) | 3.15630239 |
| 111 | protein localization to mitochondrion (GO:0070585) | 3.15557147 |
| 112 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.15392321 |
| 113 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.15392321 |
| 114 | rRNA processing (GO:0006364) | 3.12966235 |
| 115 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.11573016 |
| 116 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.10959803 |
| 117 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.09920378 |
| 118 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.09920378 |
| 119 | maturation of 5.8S rRNA (GO:0000460) | 3.05649866 |
| 120 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.05292334 |
| 121 | * negative regulation of protein ubiquitination (GO:0031397) | 3.04985618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.73760917 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.33921287 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.24811980 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.14579704 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.14347508 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.08298456 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.83850331 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.80215601 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.63312965 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.62433814 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.57799837 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.32093408 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.18498825 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.99305074 |
| 15 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.88345493 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.88280170 |
| 17 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.78029241 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.72511681 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.71315783 |
| 20 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.67740681 |
| 21 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.62182791 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.57443423 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.55983954 |
| 24 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.49515189 |
| 25 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.42778328 |
| 26 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.39034994 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.36538162 |
| 28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.33780098 |
| 29 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.25372186 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.09597659 |
| 31 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.08203759 |
| 32 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.04280062 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.01440882 |
| 34 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.95809622 |
| 35 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.83342714 |
| 36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.79473692 |
| 37 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.79150457 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71509616 |
| 39 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70440858 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70326756 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67909805 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.66104609 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65699874 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63115946 |
| 45 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60209940 |
| 46 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.58866825 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55097651 |
| 48 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.52004405 |
| 49 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.48544357 |
| 50 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46270778 |
| 51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.45511905 |
| 52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.43484335 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37633781 |
| 54 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.37156955 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.35364023 |
| 56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34147782 |
| 57 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.29721855 |
| 58 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29097945 |
| 59 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.28557781 |
| 60 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27806354 |
| 61 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.23764649 |
| 62 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.21477101 |
| 63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.21421641 |
| 64 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.21071517 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19719646 |
| 66 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.19385758 |
| 67 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.18974388 |
| 68 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.14442572 |
| 69 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11534835 |
| 70 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.10133424 |
| 71 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08573059 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07480796 |
| 73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06891599 |
| 74 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05229402 |
| 75 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.05074309 |
| 76 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02333972 |
| 77 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.99912912 |
| 78 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98447059 |
| 79 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.97671991 |
| 80 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.93692401 |
| 81 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91911987 |
| 82 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.91165480 |
| 83 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89045509 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88151989 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87776513 |
| 86 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.87081761 |
| 87 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.86042535 |
| 88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85688143 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85290212 |
| 90 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.84981573 |
| 91 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.82556963 |
| 92 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82129746 |
| 93 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79644057 |
| 94 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.78726209 |
| 95 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.76928384 |
| 96 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.76445358 |
| 97 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.75772366 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.74990659 |
| 99 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74746618 |
| 100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.74200591 |
| 101 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.73884587 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.71672898 |
| 103 | EWS_26573619_Chip-Seq_HEK293_Human | 0.71546968 |
| 104 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.71456007 |
| 105 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70759708 |
| 106 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.70088129 |
| 107 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.68266090 |
| 108 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.67571985 |
| 109 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.67422281 |
| 110 | VDR_22108803_ChIP-Seq_LS180_Human | 0.66723167 |
| 111 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.65920624 |
| 112 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.64775183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 5.22518635 |
| 2 | MP0009379_abnormal_foot_pigmentation | 4.25847387 |
| 3 | * MP0006036_abnormal_mitochondrial_physio | 3.60380538 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.22376383 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 2.94458300 |
| 6 | MP0001529_abnormal_vocalization | 2.91374646 |
| 7 | MP0003186_abnormal_redox_activity | 2.83668549 |
| 8 | MP0006035_abnormal_mitochondrial_morpho | 2.80236483 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.59449032 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.41935603 |
| 11 | MP0008058_abnormal_DNA_repair | 2.36263191 |
| 12 | MP0001764_abnormal_homeostasis | 2.35869440 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.25050526 |
| 14 | MP0004147_increased_porphyrin_level | 2.19781195 |
| 15 | MP0003646_muscle_fatigue | 2.11143284 |
| 16 | MP0000749_muscle_degeneration | 2.07879807 |
| 17 | MP0008057_abnormal_DNA_replication | 1.99772809 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 1.90423592 |
| 19 | MP0008932_abnormal_embryonic_tissue | 1.90035549 |
| 20 | MP0009697_abnormal_copulation | 1.87555157 |
| 21 | MP0003077_abnormal_cell_cycle | 1.87059893 |
| 22 | MP0005266_abnormal_metabolism | 1.79160789 |
| 23 | MP0005360_urolithiasis | 1.78562589 |
| 24 | MP0002102_abnormal_ear_morphology | 1.71791984 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.71524480 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.68791980 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.66849080 |
| 28 | MP0003111_abnormal_nucleus_morphology | 1.66242223 |
| 29 | MP0003786_premature_aging | 1.64354212 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.64127088 |
| 31 | MP0002822_catalepsy | 1.62928164 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.60310181 |
| 33 | * MP0001905_abnormal_dopamine_level | 1.59668965 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.59386911 |
| 35 | MP0003941_abnormal_skin_development | 1.58510203 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.57046748 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.56908881 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.56885023 |
| 39 | MP0005332_abnormal_amino_acid | 1.56389119 |
| 40 | MP0004043_abnormal_pH_regulation | 1.49849136 |
| 41 | MP0004142_abnormal_muscle_tone | 1.46902368 |
| 42 | MP0003718_maternal_effect | 1.45409621 |
| 43 | MP0008789_abnormal_olfactory_epithelium | 1.43873584 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.42636077 |
| 45 | MP0003195_calcinosis | 1.39755895 |
| 46 | MP0000372_irregular_coat_pigmentation | 1.36741628 |
| 47 | MP0003136_yellow_coat_color | 1.34511682 |
| 48 | MP0008007_abnormal_cellular_replicative | 1.29987609 |
| 49 | MP0000358_abnormal_cell_content/ | 1.29586133 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.29341299 |
| 51 | MP0005365_abnormal_bile_salt | 1.29003275 |
| 52 | MP0001188_hyperpigmentation | 1.28003422 |
| 53 | MP0005376_homeostasis/metabolism_phenot | 1.25159493 |
| 54 | MP0004036_abnormal_muscle_relaxation | 1.22486870 |
| 55 | MP0000751_myopathy | 1.14813647 |
| 56 | MP0003123_paternal_imprinting | 1.14655566 |
| 57 | MP0004133_heterotaxia | 1.14532931 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.12982117 |
| 59 | MP0001984_abnormal_olfaction | 1.12542173 |
| 60 | MP0002132_abnormal_respiratory_system | 1.11894653 |
| 61 | MP0008995_early_reproductive_senescence | 1.11523941 |
| 62 | MP0005083_abnormal_biliary_tract | 1.10948595 |
| 63 | MP0002210_abnormal_sex_determination | 1.09544673 |
| 64 | MP0002090_abnormal_vision | 1.08779276 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05021174 |
| 66 | MP0009046_muscle_twitch | 1.04725116 |
| 67 | MP0002269_muscular_atrophy | 1.02363982 |
| 68 | MP0000747_muscle_weakness | 1.02059627 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.02041840 |
| 70 | MP0003011_delayed_dark_adaptation | 1.01768551 |
| 71 | MP0008877_abnormal_DNA_methylation | 1.01168656 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.00059444 |
| 73 | MP0010030_abnormal_orbit_morphology | 0.99989812 |
| 74 | MP0005408_hypopigmentation | 0.99896592 |
| 75 | MP0000350_abnormal_cell_proliferation | 0.99796390 |
| 76 | MP0005253_abnormal_eye_physiology | 0.97628060 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 0.96844462 |
| 78 | MP0002163_abnormal_gland_morphology | 0.96339795 |
| 79 | MP0002736_abnormal_nociception_after | 0.96017581 |
| 80 | MP0002938_white_spotting | 0.94830969 |
| 81 | MP0001929_abnormal_gametogenesis | 0.94004188 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.90556768 |
| 83 | MP0009643_abnormal_urine_homeostasis | 0.88298131 |
| 84 | MP0001293_anophthalmia | 0.88062913 |
| 85 | MP0002106_abnormal_muscle_physiology | 0.86760064 |
| 86 | MP0005646_abnormal_pituitary_gland | 0.86620676 |
| 87 | MP0001727_abnormal_embryo_implantation | 0.85860320 |
| 88 | MP0002160_abnormal_reproductive_system | 0.85120909 |
| 89 | MP0001145_abnormal_male_reproductive | 0.85017364 |
| 90 | MP0000653_abnormal_sex_gland | 0.84445290 |
| 91 | MP0000566_synostosis | 0.83664700 |
| 92 | MP0010386_abnormal_urinary_bladder | 0.82894645 |
| 93 | MP0001881_abnormal_mammary_gland | 0.82849344 |
| 94 | MP0000678_abnormal_parathyroid_gland | 0.82727512 |
| 95 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81887741 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.81591540 |
| 97 | MP0001730_embryonic_growth_arrest | 0.80530241 |
| 98 | MP0000750_abnormal_muscle_regeneration | 0.79000458 |
| 99 | MP0005551_abnormal_eye_electrophysiolog | 0.77871901 |
| 100 | MP0001919_abnormal_reproductive_system | 0.77452731 |
| 101 | MP0003137_abnormal_impulse_conducting | 0.77071500 |
| 102 | MP0002751_abnormal_autonomic_nervous | 0.76175745 |
| 103 | MP0001485_abnormal_pinna_reflex | 0.76083166 |
| 104 | MP0005330_cardiomyopathy | 0.75606620 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.75592606 |
| 106 | MP0005394_taste/olfaction_phenotype | 0.74467183 |
| 107 | MP0005499_abnormal_olfactory_system | 0.74467183 |
| 108 | MP0005410_abnormal_fertilization | 0.73372874 |
| 109 | MP0001697_abnormal_embryo_size | 0.73123054 |
| 110 | MP0000313_abnormal_cell_death | 0.73045413 |
| 111 | MP0003315_abnormal_perineum_morphology | 0.72522386 |
| 112 | MP0002735_abnormal_chemical_nociception | 0.72154854 |
| 113 | * MP0008872_abnormal_physiological_respon | 0.69369206 |
| 114 | MP0002234_abnormal_pharynx_morphology | 0.68962737 |
| 115 | MP0006072_abnormal_retinal_apoptosis | 0.68941405 |
| 116 | MP0005369_muscle_phenotype | 0.66534293 |
| 117 | MP0003880_abnormal_central_pattern | 0.66374310 |
| 118 | MP0002080_prenatal_lethality | 0.66228081 |
| 119 | MP0005084_abnormal_gallbladder_morpholo | 0.65377431 |
| 120 | MP0005174_abnormal_tail_pigmentation | 0.64670949 |
| 121 | MP0005171_absent_coat_pigmentation | 0.64008883 |
| 122 | MP0005409_darkened_coat_color | 0.62948197 |
| 123 | MP0005389_reproductive_system_phenotype | 0.62114374 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.61925060 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60002824 |
| 126 | MP0003122_maternal_imprinting | 0.59787530 |
| 127 | MP0001853_heart_inflammation | 0.59680668 |
| 128 | MP0000759_abnormal_skeletal_muscle | 0.59262385 |
| 129 | MP0001756_abnormal_urination | 0.58457433 |
| 130 | MP0003698_abnormal_male_reproductive | 0.58177710 |
| 131 | MP0001119_abnormal_female_reproductive | 0.57883493 |
| 132 | MP0004084_abnormal_cardiac_muscle | 0.57609608 |
| 133 | * MP0002272_abnormal_nervous_system | 0.56513143 |
| 134 | MP0002095_abnormal_skin_pigmentation | 0.54971635 |
| 135 | * MP0008873_increased_physiological_sensi | 0.54876388 |
| 136 | MP0005535_abnormal_body_temperature | 0.54475796 |
| 137 | MP0002019_abnormal_tumor_incidence | 0.54026514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.45114668 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.12060617 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.91472687 |
| 4 | Hepatocellular necrosis (HP:0001404) | 5.76559226 |
| 5 | Acute encephalopathy (HP:0006846) | 5.68844124 |
| 6 | Hepatic necrosis (HP:0002605) | 5.43202908 |
| 7 | Increased CSF lactate (HP:0002490) | 5.41110121 |
| 8 | Progressive macrocephaly (HP:0004481) | 5.20484825 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.48183093 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.48183093 |
| 11 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.37892324 |
| 12 | Cerebral edema (HP:0002181) | 4.33227361 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 4.20263141 |
| 14 | Abnormal number of erythroid precursors (HP:0012131) | 4.17441213 |
| 15 | Abnormality of glycolysis (HP:0004366) | 4.12434240 |
| 16 | Increased serum pyruvate (HP:0003542) | 4.12434240 |
| 17 | Increased serum lactate (HP:0002151) | 4.08281048 |
| 18 | Lipid accumulation in hepatocytes (HP:0006561) | 4.03116498 |
| 19 | Lactic acidosis (HP:0003128) | 4.00540341 |
| 20 | Exercise intolerance (HP:0003546) | 3.81932306 |
| 21 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.77005246 |
| 22 | Increased intramyocellular lipid droplets (HP:0012240) | 3.75426822 |
| 23 | 3-Methylglutaconic aciduria (HP:0003535) | 3.74239488 |
| 24 | Respiratory failure (HP:0002878) | 3.67850224 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 3.66390998 |
| 26 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.46187398 |
| 27 | Increased muscle lipid content (HP:0009058) | 3.42290243 |
| 28 | Reticulocytopenia (HP:0001896) | 3.36952102 |
| 29 | Leukodystrophy (HP:0002415) | 3.17323375 |
| 30 | Macrocytic anemia (HP:0001972) | 3.06583480 |
| 31 | Optic disc pallor (HP:0000543) | 3.00846141 |
| 32 | CNS demyelination (HP:0007305) | 2.98869051 |
| 33 | Lethargy (HP:0001254) | 2.89083875 |
| 34 | Respiratory difficulties (HP:0002880) | 2.85614860 |
| 35 | Exertional dyspnea (HP:0002875) | 2.81849613 |
| 36 | Aplastic anemia (HP:0001915) | 2.80032561 |
| 37 | Microvesicular hepatic steatosis (HP:0001414) | 2.76362017 |
| 38 | Emotional lability (HP:0000712) | 2.76318233 |
| 39 | Degeneration of anterior horn cells (HP:0002398) | 2.60675036 |
| 40 | Abnormality of the anterior horn cell (HP:0006802) | 2.60675036 |
| 41 | Methylmalonic acidemia (HP:0002912) | 2.53652988 |
| 42 | Oral leukoplakia (HP:0002745) | 2.53139349 |
| 43 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.48738801 |
| 44 | Cerebral hypomyelination (HP:0006808) | 2.48229747 |
| 45 | Glycosuria (HP:0003076) | 2.42574709 |
| 46 | Abnormality of urine glucose concentration (HP:0011016) | 2.42574709 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 2.39994499 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.37647214 |
| 49 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.36857751 |
| 50 | Type I transferrin isoform profile (HP:0003642) | 2.36643932 |
| 51 | Abnormality of renal resorption (HP:0011038) | 2.36524031 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34981346 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.34981346 |
| 54 | Pallor (HP:0000980) | 2.33018073 |
| 55 | Abnormality of placental membranes (HP:0011409) | 2.31154589 |
| 56 | Amniotic constriction ring (HP:0009775) | 2.31154589 |
| 57 | Hyperphosphaturia (HP:0003109) | 2.28955940 |
| 58 | Hypobetalipoproteinemia (HP:0003563) | 2.28203393 |
| 59 | Rhabdomyolysis (HP:0003201) | 2.23697596 |
| 60 | Hypothermia (HP:0002045) | 2.23387878 |
| 61 | Birth length less than 3rd percentile (HP:0003561) | 2.22299886 |
| 62 | Abnormality of serum amino acid levels (HP:0003112) | 2.20436310 |
| 63 | Methylmalonic aciduria (HP:0012120) | 2.19716555 |
| 64 | Ragged-red muscle fibers (HP:0003200) | 2.18578294 |
| 65 | Testicular atrophy (HP:0000029) | 2.15439843 |
| 66 | Neuroendocrine neoplasm (HP:0100634) | 2.13852550 |
| 67 | Vomiting (HP:0002013) | 2.04546567 |
| 68 | Abnormality of alanine metabolism (HP:0010916) | 2.03317376 |
| 69 | Hyperalaninemia (HP:0003348) | 2.03317376 |
| 70 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.03317376 |
| 71 | Myoglobinuria (HP:0002913) | 2.02528736 |
| 72 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.01812452 |
| 73 | Congenital, generalized hypertrichosis (HP:0004540) | 2.01528218 |
| 74 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.01057725 |
| 75 | Pancytopenia (HP:0001876) | 2.00646359 |
| 76 | Abnormality of the labia minora (HP:0012880) | 2.00239160 |
| 77 | Gliosis (HP:0002171) | 1.99589777 |
| 78 | Hyperglycinemia (HP:0002154) | 1.95152694 |
| 79 | Multiple enchondromatosis (HP:0005701) | 1.93585438 |
| 80 | Unsteady gait (HP:0002317) | 1.93085698 |
| 81 | Hypoglycemic coma (HP:0001325) | 1.92993497 |
| 82 | Pheochromocytoma (HP:0002666) | 1.91287090 |
| 83 | Cholecystitis (HP:0001082) | 1.89679630 |
| 84 | Abnormal gallbladder physiology (HP:0012438) | 1.89679630 |
| 85 | Colon cancer (HP:0003003) | 1.83789273 |
| 86 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83481584 |
| 87 | Palpitations (HP:0001962) | 1.82703667 |
| 88 | Meckel diverticulum (HP:0002245) | 1.81155819 |
| 89 | Metabolic acidosis (HP:0001942) | 1.81153114 |
| 90 | X-linked dominant inheritance (HP:0001423) | 1.80615913 |
| 91 | Megaloblastic anemia (HP:0001889) | 1.80160267 |
| 92 | Abnormal pupillary function (HP:0007686) | 1.78294761 |
| 93 | Sparse eyelashes (HP:0000653) | 1.78045916 |
| 94 | CNS hypomyelination (HP:0003429) | 1.77548626 |
| 95 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.77530668 |
| 96 | Proximal tubulopathy (HP:0000114) | 1.76465317 |
| 97 | Delayed CNS myelination (HP:0002188) | 1.75243220 |
| 98 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.73954628 |
| 99 | Delusions (HP:0000746) | 1.73009319 |
| 100 | Nausea (HP:0002018) | 1.72890923 |
| 101 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.71956885 |
| 102 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.71956885 |
| 103 | Abnormal protein glycosylation (HP:0012346) | 1.71956885 |
| 104 | Abnormal glycosylation (HP:0012345) | 1.71956885 |
| 105 | Blindness (HP:0000618) | 1.71867922 |
| 106 | Abnormal urine phosphate concentration (HP:0012599) | 1.71028052 |
| 107 | Abnormality of the ileum (HP:0001549) | 1.70960571 |
| 108 | Poor suck (HP:0002033) | 1.70154986 |
| 109 | Nemaline bodies (HP:0003798) | 1.68322808 |
| 110 | Neoplasm of the adrenal gland (HP:0100631) | 1.67544656 |
| 111 | Progressive external ophthalmoplegia (HP:0000590) | 1.67050546 |
| 112 | Renal tubular dysfunction (HP:0000124) | 1.67026764 |
| 113 | Reduced antithrombin III activity (HP:0001976) | 1.66536945 |
| 114 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.66236134 |
| 115 | Progressive muscle weakness (HP:0003323) | 1.65623843 |
| 116 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.65508184 |
| 117 | Hyperammonemia (HP:0001987) | 1.64995926 |
| 118 | Muscle fiber inclusion bodies (HP:0100299) | 1.64557842 |
| 119 | Rough bone trabeculation (HP:0100670) | 1.64185597 |
| 120 | Neoplasm of head and neck (HP:0012288) | 1.62835285 |
| 121 | Esophageal neoplasm (HP:0100751) | 1.62835285 |
| 122 | Breast hypoplasia (HP:0003187) | 1.62779977 |
| 123 | Abnormality of the preputium (HP:0100587) | 1.62490854 |
| 124 | Hypoplasia of the pons (HP:0012110) | 1.61489807 |
| 125 | Pancreatic fibrosis (HP:0100732) | 1.60019380 |
| 126 | Abnormality of the pons (HP:0007361) | 1.58029983 |
| 127 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.57998526 |
| 128 | Abnormality of midbrain morphology (HP:0002418) | 1.57869494 |
| 129 | Molar tooth sign on MRI (HP:0002419) | 1.57869494 |
| 130 | Progressive microcephaly (HP:0000253) | 1.55730311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.91315902 |
| 2 | STK16 | 4.34297378 |
| 3 | BUB1 | 4.04830800 |
| 4 | EIF2AK1 | 3.36626664 |
| 5 | NME2 | 3.12929390 |
| 6 | NME1 | 3.04607779 |
| 7 | BCKDK | 2.86003619 |
| 8 | WEE1 | 2.75907139 |
| 9 | NEK1 | 2.72828943 |
| 10 | MAP3K12 | 2.60156247 |
| 11 | VRK1 | 2.57475322 |
| 12 | EIF2AK3 | 2.47908478 |
| 13 | TSSK6 | 2.28032406 |
| 14 | SRPK1 | 2.25784042 |
| 15 | MYLK | 2.04051265 |
| 16 | OBSCN | 1.95085452 |
| 17 | TLK1 | 1.74579991 |
| 18 | CDC7 | 1.64561658 |
| 19 | TESK2 | 1.56512458 |
| 20 | PIM2 | 1.52662733 |
| 21 | NUAK1 | 1.46174169 |
| 22 | TRIM28 | 1.40638420 |
| 23 | ACVR1B | 1.39967377 |
| 24 | BRSK2 | 1.38751995 |
| 25 | CCNB1 | 1.36092433 |
| 26 | PASK | 1.31902544 |
| 27 | CDK8 | 1.25844874 |
| 28 | CDK19 | 1.25753503 |
| 29 | DAPK1 | 1.22990348 |
| 30 | KDR | 1.17040322 |
| 31 | MAP4K2 | 1.15990804 |
| 32 | PIK3CG | 1.15319948 |
| 33 | LIMK1 | 1.13169816 |
| 34 | MST4 | 1.11670661 |
| 35 | AURKA | 1.10643908 |
| 36 | BRAF | 1.08983352 |
| 37 | RPS6KB2 | 1.08336904 |
| 38 | TAF1 | 1.05840605 |
| 39 | MUSK | 1.03440841 |
| 40 | ADRBK2 | 1.03359282 |
| 41 | PLK4 | 1.01986708 |
| 42 | MAPKAPK3 | 0.99482636 |
| 43 | MAP3K11 | 0.99395208 |
| 44 | FLT3 | 0.96782165 |
| 45 | PDK4 | 0.96444476 |
| 46 | PDK3 | 0.96444476 |
| 47 | PLK2 | 0.95742272 |
| 48 | PLK1 | 0.95363779 |
| 49 | ARAF | 0.95036178 |
| 50 | MKNK1 | 0.95015228 |
| 51 | BRSK1 | 0.94729544 |
| 52 | ZAK | 0.94003589 |
| 53 | PBK | 0.92925957 |
| 54 | CSNK1G1 | 0.91910364 |
| 55 | CSNK1G2 | 0.86975337 |
| 56 | GRK7 | 0.82458415 |
| 57 | PLK3 | 0.81880452 |
| 58 | CSNK2A2 | 0.81093823 |
| 59 | CASK | 0.80794743 |
| 60 | TESK1 | 0.79660406 |
| 61 | AURKB | 0.79625512 |
| 62 | MAPKAPK5 | 0.78980646 |
| 63 | ILK | 0.78319355 |
| 64 | CSNK2A1 | 0.77105028 |
| 65 | CSNK1A1L | 0.76207246 |
| 66 | OXSR1 | 0.75504828 |
| 67 | PINK1 | 0.74672842 |
| 68 | GRK1 | 0.73413049 |
| 69 | GRK5 | 0.70947320 |
| 70 | BMPR1B | 0.69517020 |
| 71 | CHEK2 | 0.69482528 |
| 72 | ABL2 | 0.67751134 |
| 73 | TTK | 0.67705977 |
| 74 | CDK7 | 0.67577374 |
| 75 | ATR | 0.65026677 |
| 76 | DYRK2 | 0.64321122 |
| 77 | TGFBR1 | 0.63231648 |
| 78 | MAP2K7 | 0.62490707 |
| 79 | CSNK1G3 | 0.62094879 |
| 80 | SCYL2 | 0.61503492 |
| 81 | PAK4 | 0.60495164 |
| 82 | MAP2K6 | 0.59767571 |
| 83 | WNK3 | 0.59344616 |
| 84 | DAPK3 | 0.58886926 |
| 85 | TNIK | 0.58320683 |
| 86 | BCR | 0.58110071 |
| 87 | GRK6 | 0.58006107 |
| 88 | DYRK3 | 0.57233585 |
| 89 | MAP2K3 | 0.55068094 |
| 90 | EIF2AK2 | 0.53388344 |
| 91 | WNK4 | 0.50743190 |
| 92 | STK4 | 0.49541080 |
| 93 | MINK1 | 0.49473020 |
| 94 | ALK | 0.47877233 |
| 95 | PDK2 | 0.47223172 |
| 96 | PRKCI | 0.46247008 |
| 97 | ADRBK1 | 0.45387512 |
| 98 | PRKCG | 0.43384079 |
| 99 | CLK1 | 0.42108217 |
| 100 | TEC | 0.42006587 |
| 101 | PAK1 | 0.41152724 |
| 102 | MAPK4 | 0.39904652 |
| 103 | CAMK2G | 0.39879437 |
| 104 | CAMK2B | 0.39816610 |
| 105 | ATM | 0.39230477 |
| 106 | UHMK1 | 0.36908894 |
| 107 | CDK14 | 0.36155540 |
| 108 | CHEK1 | 0.36104783 |
| 109 | ERBB3 | 0.35396487 |
| 110 | MKNK2 | 0.35387877 |
| 111 | CSNK1E | 0.34843300 |
| 112 | MAP3K3 | 0.34670668 |
| 113 | LRRK2 | 0.34649058 |
| 114 | BTK | 0.33621724 |
| 115 | RPS6KA5 | 0.33235642 |
| 116 | PNCK | 0.32071192 |
| 117 | PHKG1 | 0.31795336 |
| 118 | PHKG2 | 0.31795336 |
| 119 | CSNK1A1 | 0.31311168 |
| 120 | SIK3 | 0.29954447 |
| 121 | RPS6KC1 | 0.29604767 |
| 122 | RPS6KL1 | 0.29604767 |
| 123 | CAMK2D | 0.29479019 |
| 124 | CDK18 | 0.28159787 |
| 125 | CDK11A | 0.27565267 |
| 126 | TXK | 0.27454576 |
| 127 | RPS6KA6 | 0.26201660 |
| 128 | SYK | 0.26191908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.25029081 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.23648010 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.10712980 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.73693186 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.98024186 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.81045279 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.67179796 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.66328390 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.57075173 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.49132393 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.34936442 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.25362470 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.13543920 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.92672130 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.84855915 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.84150965 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.83079161 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.67187111 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.64327815 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62129629 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.58857587 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.54680758 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.53577501 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.46312358 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.39052386 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.37782754 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32845651 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31424142 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30907652 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.29353306 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28660111 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22876382 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22591993 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.21784010 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.20668369 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18625955 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.14524669 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12777434 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08027315 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.05151250 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03798095 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00784546 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00224173 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97801178 |
| 45 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97640246 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95920731 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95463541 |
| 48 | Metabolic pathways_Homo sapiens_hsa01100 | 0.95420738 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94830315 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94717644 |
| 51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.94167569 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.93317846 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.86521343 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.83243008 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81795429 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81467474 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79142229 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.78387006 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78329281 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76335047 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75115277 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.72296944 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72141653 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70521281 |
| 65 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69243085 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68346705 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66717355 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66435409 |
| 69 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65570410 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62107574 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.61737306 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61278822 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60513221 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58277792 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56847526 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56433220 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54609913 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52720510 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51364254 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44978722 |
| 81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43907962 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43093996 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38421272 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37467111 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35083496 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35011630 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34661079 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33722978 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.33148951 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32941691 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31533935 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31473048 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29681385 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28744168 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27146181 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.24709976 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.23929583 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.23388677 |
| 99 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.22919365 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22915618 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.18224004 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.17620085 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15911546 |
| 104 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.15388430 |
| 105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.15272062 |
| 106 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.15258749 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.14511156 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13373558 |
| 109 | Asthma_Homo sapiens_hsa05310 | 0.11257542 |
| 110 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.10465461 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.09959654 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.09647026 |

